Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Bayer Launches Breakthrough Therapy AliqopaTM (Copanlisib) for Treatment of Marginal Zone Lymphoma
Aliqopa (Copanlisib) is administered intravenously and exhibits inhibitory activity against phosphatidylinositol-3-Kinase (PL3K), primarily targeting the PL3K-alpha and PL3K-delta isoforms expressed in malignant B cells....
Harvard Chemist's Developed Synthesis Advance Potent Anti-Malignant Tumour Agent
Harvard University chemist's synthesis of halichondrin is known to be a potent anti-cancer agent. Harvard University Chemists have achieved a landmark in drug discovery spending three decades in making it....
Novel Agent Reactivates an Immune Call by LIF Blockade
A groundbreaking therapy known as the novel agent reactivates has emerged, offering a dual mechanism of action to effectively eradicate malignant stem cells and stimulate the immune system....
A 3D-Printed Clinical Device Intended to Detect Biomarkers of Preterm Birth
The 3D-Printed device is a microchip electrophoresis device that can sensitively detect three serum biomarkers of Preterm birth (PTB)....
Cyclica Launches First-of-its-kind Ligand Design
Cyclica, a biotechnology company announced its novel, first-in-class drug design technology, Ligand Design at the Collision Conference in Toronto....
York University Scientists Discover a Novel Gene to Prevent the Spread of Muscle Cancer
York University scientists have discovered a unique set of genes in muscle cellular gene expression and differentiation that could lead to new therapeutic targets to prevent the spread of muscle cancer....
UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses
UW-Madison school of Pharmacy designed a breakthrough in creating new small molecules that penetrate into the brain where the virus resides and interfere with viral replication to stop Equine Encephalitis Viruses (EEV)....
Nanopore-based DNA Sequencing Technology to Diagnose Genetic Disorder Huntington's Disease
The world has witnessed a groundbreaking advancement in genetic disorder diagnostics with the development of nanopore-based DNA sequencing technology specifically tailored for Huntington's Disease....
Wistar Scientists Develop Innovative Synthetic DNA-based Cancer Immunotherapy Approach
Wistar scientists have developed a novel innovative synthetic DNA approach for patient-specific production of cancer-targeting molecules called bispecific T cell engagers (BiTEs)....
PhaseBio to Announce PB2452, a Novel Reversal Agent for Antiplatelet Drug Ticagrelor
PhaseBio Pharmaceuticals is planning to announce PB2452, a novel reversal agent for the Antiplatelet drug Ticagrelor. PB2452 is a novel, recombinant, human monoclonal antibody antigen-binding fragment, or Fab fragment, designed to reverse the Antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations....
